<DOC>
	<DOCNO>NCT00430742</DOCNO>
	<brief_summary>A worldwide study extension patient type 2 diabetes mellitus assess safety tolerability well effect treatment investigational drug weight loss body weight .</brief_summary>
	<brief_title>An Investigational Drug Study Assess Weight Loss Patients With Type 2 Diabetes Mellitus ( 0364-011 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Body Mass Index ( BMI ) 27 kg/m2 43 kg/m2 HbA1c 7.0 % 10 % History major psychiatric disorder Blood pressure great 160/100 Use antihyperglycemic agent metformin Triglycerides great 600 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>